Next Post

Moderna booster candidate shows strong response against Omicron subvariants

[ad_1] June 22 (Reuters) – Moderna Inc (MRNA.O) stated on Wednesday that an up to date variation of its COVID-19 vaccine developed to goal the Omicron variant also produced a strong immune response versus the quick-spreading Omicron subvariants BA.4 and BA.5, which have acquired a foothold in the U.S. in […]

Subscribe US Now